Correlation Between Aldeyra and Brainstorm Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aldeyra and Brainstorm Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aldeyra and Brainstorm Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aldeyra and Brainstorm Cell Therapeutics, you can compare the effects of market volatilities on Aldeyra and Brainstorm Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aldeyra with a short position of Brainstorm Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aldeyra and Brainstorm Cell.

Diversification Opportunities for Aldeyra and Brainstorm Cell

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Aldeyra and Brainstorm is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Aldeyra and Brainstorm Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainstorm Cell Ther and Aldeyra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aldeyra are associated (or correlated) with Brainstorm Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainstorm Cell Ther has no effect on the direction of Aldeyra i.e., Aldeyra and Brainstorm Cell go up and down completely randomly.

Pair Corralation between Aldeyra and Brainstorm Cell

Given the investment horizon of 90 days Aldeyra is expected to under-perform the Brainstorm Cell. But the stock apears to be less risky and, when comparing its historical volatility, Aldeyra is 1.43 times less risky than Brainstorm Cell. The stock trades about -0.03 of its potential returns per unit of risk. The Brainstorm Cell Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  180.00  in Brainstorm Cell Therapeutics on September 3, 2024 and sell it today you would lose (6.00) from holding Brainstorm Cell Therapeutics or give up 3.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Aldeyra  vs.  Brainstorm Cell Therapeutics

 Performance 
       Timeline  
Aldeyra 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aldeyra has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Brainstorm Cell Ther 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brainstorm Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Aldeyra and Brainstorm Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aldeyra and Brainstorm Cell

The main advantage of trading using opposite Aldeyra and Brainstorm Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aldeyra position performs unexpectedly, Brainstorm Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will offset losses from the drop in Brainstorm Cell's long position.
The idea behind Aldeyra and Brainstorm Cell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like